InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,576.98
(
0.07%
)
US TECH 100
19,927.60
(
0.17%
)
Dow Jones
39,291.97
(
-0.13%
)
Brent Oil
84.70
(
-0.84%
)
Bitcoin
58,007.25
(
2.30%
)
Post# of 252538
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

read_this_n0w

Send PM Follow Ignore
Followers 250
Posts 14020
Boards Moderated 3
Alias Born 07/07/2006

read_this_n0w

Re: researcher59 post# 172074

Friday, 03/07/2014 8:21:52 AM

Friday, March 07, 2014 8:21:52 AM

Post# of 252538
Northwest Biotherapeutics (NWBO) Said GBM Brain Cancer Trial Recommend To Continue

company announced today, in response to shareholder inquiries, that the Data Safety Monitoring Board (DSMB) has made an unblinded review of the safety data for the Company's ongoing international Phase III GBM Trial, and has recommended that the trial continue as planned.

The DSMB's review of the efficacy data is still pending.

Dr. Marnix Bosch, Chief Technical Officer of NW Bio noted, "We are pleased with the recommendation of the DSMB to continue the trial as planned. This is an important step in the ongoing progress of our Phase III trial."

To follow my postings on ihub use this link : Ihub person mark
Feedback is allways appreciated, as are other (annotated) picks

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up